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Different nutritional components are able, by modulating mitochondrial function and gut microbiota composition, to influence body composition, metabolic
homeostasis and inflammatory state. In this study, we aimed to evaluate the effects produced by the supplementation of different milks on energy balance,
inflammatory state, oxidative stress and antioxidant/detoxifying enzyme activities and to investigate the role of the mitochondrial efficiency and the gut
microbiota in the regulation of metabolic functions in an animal model. We compared the intake of human milk, gold standard for infant nutrition, with
equicaloric supplementation of donkey milk, the best substitute for newborns due to its nutritional properties, and cow milk, the primary marketed product. The
results showed a hypolipidemic effect produced by donkey and human milk intake in parallel with enhanced mitochondrial activity/proton leakage. Reduced
mitochondrial energy efficiency and proinflammatory signals (tumor necrosis factor α, interleukin-1 and lipopolysaccharide levels) were associated with a
significant increase of antioxidants (total thiols) and detoxifying enzyme activities (glutathione-S-transferase, NADH quinone oxidoreductase) in donkey- and
human milk-treated animals. The beneficial effects were attributable, at least in part, to the activation of the nuclear factor erythroid-2-related factor-2 pathway.
Moreover, the metabolic benefits induced by human and donkey milk may be related to the modulation of gut microbiota. In fact, milk treatments uniquely
affected the proportions of bacterial phyla and genera, and we hypothesized that the increased concentration of fecal butyrate in human and donkey milk-
treated rats was related to the improved lipid and glucose metabolism and detoxifying activities.
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Evidence from animal and human studies indicates that mitochon-
drial function and gut microbiota inﬂuence metabolic homeostasis.
Mitochondria play a central role in cellular function and metab-
olism by coupling cellular respiration to the production of ATP.
However, this coupling is not perfectly tight. Approximately 20% of the
standard metabolic rate in mammals is due to a leak of protons across
the mitochondrial inner membrane (basal proton leak) in a manner
that uncouples cellular respiration from ATP production, thereby
generating heat [1]. In addition to this basal leak, there is an inducible
leak of protons catalyzed by free fatty acids (FFAs) [2]. Recent work
suggests that an inducible proton leakmight have an important role in
the protection against reactive oxygen species (ROS) [3]. Moreover,
mitochondria play a key role in cell signaling through production of
ROS that modulate redox signaling. Nuclear factor E2-related factor-2
(Nrf2) is a transcription factor that orchestrates the expression of
battery of antioxidant and detoxiﬁcation genes under both basal and
stress condition [4]. Nrf2 also modulates genes involved in metabolice CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Body composition and energy balance. Body lipid (A), body protein (B), body water content (C), metabolisable energy intake (D), body weight gain (E), energy expenditure
(F), gross efﬁciency (G), lipid gain (H) and protein gain (I) were reported. The results are expressed as themeans±S.E. from n=7 animals/group. Different superscripted letters indicate
statistically signiﬁcant differences (Pb.05).
Table 1
Serum parameters
Control CM DM HM
Glucose (mg/dl) 138.6±2.1a 130.1±5.7a 112.1±2.7b 112.7±3.7b
Insulin (μg/l) 0.273±0.018a 0.274±0.019a 0.271±0.019a 0.201±0.013b
HOMA index 2.19±0.12a 2.09±0.13a 1.75±0.12b 1.314±0.10c
Triglycerides (mg/dl) 116±5.3a 132±7.5a 90±4.1b 120±5.2a
Total cholesterol (mg/dl) 61±1.6a 63±1.1a 58±1.2a 59±1.5a
ALT (U/l) 67±2.0a 71±3.2a 62±2.0a 44±2.6b
Data are the means ± S.E. Data with different superscripted letters are signiﬁcantly
different (Pb.05).
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pro-lipolytic hormone and peroxisome proliferator-activated recep-
tors (PPARs), which play an important role in nutrient homeostasis
[5]. Notably, the link between metabolism, ROS homeostasis and
mitochondrial metabolism is further indicated by the role played by
PPARγ coactivators-1 (PGC-1). Among them, PGC-1α plays an
important role in mitochondrial biogenesis and in the regulation of
genes responsible for ROS detoxiﬁcation [6], while PGC-1β is involved
in mitochondrial metabolism and its activation exerted a protective
effects from lipid overload [7].
Animal and human studies indicate that themetabolic function develops
primarily after birth when the newborn is ﬁrst exposed to nutrition via the
gastrointestinal tract and that the composition of the gut microbiota
inﬂuences body composition, digestion andmetabolic homeostasis [8,9].
Phylogenic changes in gutmicrobiota composition and theproduction
of bacterial metabolites, including short-chain fatty acids (SCFAs), can
interact with reach host tissues to act as metabolic regulators and to
control energy metabolism and inﬂammatory state [10].Therefore, nutritional strategies are able, by inﬂuencing the
mitochondrial function [11,12] and microbiota composition, to favor
the appropriate development of metabolic and immune system
functions, and this strategy is now considered a feasible means to
prevent diseases such as obesity, diabetes and allergies [8,9].
Table 2
Immunomodulatory markers
Control CM DM HM
TNF-α (ng/ml) 0.092±0.006a 0.090±0.005a 0.055±0.005b 0.058±0.005b
MCP-1 (ng/ml) 3.62±0.15a 3.82±0.22a 3.29±0.22a 3.87±0.32a
IL-1 (pg/ml) 56.4±3.3a 64.0±2.1a 42.9±3.4b 42.2±3.9b
IL-10 (ng/ml) 0.061±0.003a 0.134±0.008b 0.177±0.012c 0.200±0.005d
LPS (EU/ml) 0.704±0.028a 0.668±0.025a 0.584±0.014b 0.580±0.015b
Data are the means±S.E. Data with different superscripted letters are signiﬁcantly
different (Pb.05).
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is well established. Humanmilk (HM) is the natural food of all human
infants; it provides an adequate supply of all nutrients necessary to
support growth and development and even has a key role in
preventing overweight and obesity throughout life in addition to
providing immunoregulatory components [13]. Unfortunately, a very
large population of infants are deprived of their natural food at a
proportion that greatly exceeds the possible deﬁciencies of their
mothers. The rate of cowmilk (CM) consumption in theﬁrstmonths of
life is high inWestern countries, which has been suggested as a potential
factor contributing to the increasing burden of obesity and related
disorders [13]. The overall proportion of nutrients contained in CM, such
as protein content and quality, fatty acid proﬁle, iron level and the near
absence of nondigestible carbohydrates, may pose health concerns for
children aged b1 year [14]. Moreover, CM intake in the ﬁrstmonths of life
has raised concerns because of its association with allergies [15].
Consistently during recent years, milks frommonogastric animals,
rather than from ruminant species, have been indicated to be more
suitable for human nutrition based on their physicochemical proper-
ties. Among these, donkey milk (DM) has been suggested as the best
potential substitute for HM due to its composition [16]. Moreover, as a
result of its remarkable nutritional value coupled with its reduced
allergenicity and good palatability, DM has been suggested as a
replacement diet for infants affected by CM allergies when HM is not
available [17].
Comparative data on themetabolic effects of DMandCM, usingHM
as the reference standard, are still scarce. In this study, we aimed to
evaluate the differently ability of DM, CM and HM, by modulating
mitochondrial function and gut microbiota, to affect energy balance,
lipid and glucose metabolism, inﬂammatory and oxidative stress in
animal model.
2. Materials and methods
Male Wistar rats (Charles River, Calco, Lecco, Italy) were individually caged in a
temperature-controlled room and exposed to a daily 12- to 12-h light–dark cycle with
free access to chow and drinking water. Young animals (60 days old) (average weight,
345 g) were used; one group (n=7) was sacriﬁced at the beginning of the study to
establish baseline measurements. The remaining rats were divided into four
experimental groups (n=7): three groups were supplemented with equicaloric intake
(82 kJ) of raw CM, DM or HM (21, 48 or 22ml/day, respectively) for 4 weeks; the group
that did not receivemilk supplementwas used as control. Despite the different volumes
used, the energy density provided by the different milk supplements was comparable
(energetic composition of diets are reported in Supplementary Table S1 and S2).
At the end of the treatments, the animals were anesthetized by intraperitoneal
injection of chloral hydrate (40 mg/100 g body weight), and blood was taken from the
inferior cava and portal vein. The liver was removed and subdivided; samples not
immediately used for mitochondrial preparation were frozen and stored at−80°C.
All experimentswere conducted in compliancewith national guidelines for the care
and use of research animals (D.L. 116/92, implementation of EEC directive 609/86).
2.1. Evaluation of body composition and energy balance
During the treatments, the body weights and food intake were monitored daily to
calculate weight gain and gross energy intake. Spilled food and feces were collected
daily for precise food intake calculation. Energy balance assessments were conducted
over the 4 weeks of treatment by the comparative carcass evaluation [18].
Metabolizable energy intake was obtained by subtracting the energy measured in the
feces and urine from the gross energy intake, whichwas determined from the daily food
consumption and gross energy density. The gross energy density for the standard diet,
CM, DM or HM (15.8, 14.04, 13.79 or 14.01 kJ/g, respectively) as well as the energy
density of the feces and the carcasses were determined by bomb calorimetry (Parr
adiabatic calorimeter; Parr Instrument Co., Moline, IL, USA). The evaluation of theFig. 2. Coupling efﬁciency in the liver mitochondria. Liver mitochondrial respiration rates wer
substrates. Carnitine-palmitoyl transferase (CPT) activity was reported (D). Citrate synthase
mitochondrial protein mass was calculated as the ratio between CS activity in the homogenate
measured in livermitochondria. Representative immunoblot of UCP2 expression in livermitoch
intensity in arbitrary units (H). Intracellular H2O2 yield (I) and the basal aconitase/total aconitas
group. Different superscripted letters indicate statistically signiﬁcant differences (Pb.05).energy, fat and protein content in animal carcasses was conducted according to a
published protocol [18]. Energy efﬁciency was calculated as the percentage of body
energy retained per metabolizable energy intake, and energy expenditure was
determined as the difference between metabolizable energy intake and energy gain.
2.2. Mitochondrial parameters
Mitochondrial isolation, oxygen consumption and proton leakage measurements
were performed as previously reported [19]. Oxygen consumption (polarographically
measured using a Clark-type electrode)wasmeasured in the presence of substrates and
ADP (state 3) and in the presence of substrates alone (state 4), and their ratio
(respiratory control ratio, or RCR) was calculated. The rate of mitochondrial fatty acid
oxidation was assessed in the presence of palmitoyl-L-carnitine. Mitochondrial proton
leakage was assessed by a titration of the steady-state respiration rate as a function of
the mitochondrial membrane potential in liver mitochondria. This titration curve is an
indirect measurement of proton leakage because the steady-state oxygen consumption
rate (i.e., proton efﬂux rate) in nonphosphorylating mitochondria is equivalent to the
proton inﬂux rate due to proton leakage. The CPT system and aconitase activity were
measured spectrophotometrically [20,21]. The rate of mitochondrial H2O2 release was
assayed by following the linear increase in ﬂuorescence due to the oxidation of
homovanillic acid in the presence of horseradish peroxidase [22].
2.3. Liver lipid content, redox state and Nrf2-activated enzyme activities
Total hepatic lipid content was estimated by using the Folch method [23]. Total
thiols [(glutathione (GSH)+glutathione disulﬁde (GSSG)] in plasma and the GSH and
GSSG concentrations in the liverweremeasuredwith the dithionitrobenzoic acid–GSSG
reductase recycling assay [24]; the GSH/GSSG ratio was used as an oxidative stress
marker. The enzymatic activities of GST and NQO1 were evaluated spectrophotomet-
rically in liver cytoplasmic extracts with standard protocols [25–27].
2.4. Quantitative real-time polymerase chain reaction analysis
Total RNAwas extracted from liver of rats fedwith the differentmilk (CM, DM, HM)
and of control rats using the TRIzol Reagent (Ambion). After DNase treatment
(Ambion), RNA was quantiﬁed using a Nanodrop 2000c spectrophotometer (Thermo-
Scientiﬁc) and reverse-transcribed (1 μg) using the Advantage RT-PCR kit (Clontech)
and oligo dT primer. Universal Probe Library Assay Design Center (https://www.roche-
applied-cience.com/sis/rtpcr/upl/index.jsp?id=UP030000) was used for designing
primers (Supplementary Table S3). The Real-Time PCR reactions were performed
using a 7500 Real-Time PCR System (Applied Biosystems) in the presence of 1× Power
Sybr Green PCR Master mix (Applied Biosystems) and 0.1 μM of each primer and 30 ng
of cDNA. The thermal protocol was as follows: 2min at 50°C, 10min at 95°C, followed by
40 cycles of 15 s at 95°C and 1 min at 60°C. For all of the genes examined, the reactions
were conducted in technical duplicates. For each well, the evaluation of PCR efﬁciency
(E) and optimal threshold cycle (CT) of the target genes (PGC1α, PGC1β, PPARα, PPARβ,
FGF21) and the endogenous control gene (β-actin) were performed using the REAL
TIME PCRMINER online tool [28]. The mean relative expression ratio (rER) of the target
genes was calculated using β-actin as the endogenous control gene and cDNA of the
control rats as the reference sample applying the formula:
rER ¼ 1þ E target geneð Þ‐ΔCT target gene= 1þ E endogenous controlð Þ‐ΔCT endogenous control ;
where ΔCT target gene is the difference between the CT value of the target gene in the
liver of the CM, DM, HM rats and the CT value of the target gene in the liver of the control
rats, ΔCTendogenous control is the difference between the CT value of the β-actin gene ine evaluated in the presence of succinate (A), glutamate (B) or palmitoyl-carnitine (C)
(CS) activity was measured in the liver homogenate and mitochondrial fractions; the
and isolated mitochondria (E). Basal (F) and fatty acid-induced proton-leakage (G) was
ondria; the bandswere quantiﬁed by densitometry. The values are expressed as relative
e ratio are reported (L). The results are expressed as themeans±S.E. from n=7 animals/
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control rats [29].
2.5. Preparation of fecal extracts
Feces were collected and were frozen at −20°C. Frozen feces were diluted with
saline solution and centrifuged at 13,000 rpm for 10 min. Supernatants were ﬁltered
(0.45 μM) and used as the fecal extracts. These extracts were stored at −20°C until
further analysis.
2.6. Quantification of fecal SCFAs concentrations
Frozen fecal extracts were acidiﬁed with 20 μl 85% phosphoric acid and 0.5 ml ethyl
acetate. The contents were mixed by vortexing, centrifuged at 14,000 rpm for 1 h and
extracted in duplicate. A quantity of the pooled extract containing the acidiﬁed SCFAs
was transferred into a 2-ml glass vial and loaded onto an Agilent technologies 7890 gas
chromatography system with an automatic loader/injector. The GC column was an
Agilent J&W DB-FFAP (Agilent Technologies, Leini, TO, Italy) of length 30 m, internal
diameter 0.25 mm and ﬁlm thickness 0.25 μm. The GC was programmed to achieve the
following run parameters: initial temperature 90°C, hold 0.5 min, ramp 20°C/min, ﬁnal
temperature 190°C, and total run time 8.0 min. Gas ﬂow was set at 7.7 ml/min splitless
to maintain 3.26 psi column head pressure with a septum purge of 2.0 ml/min.
Detection was achieved using a ﬂame ionisation detector. Peaks were identiﬁed using a
mixed external standard and quantiﬁed by the peak height/internal standard ratio.
2.7. Microbiota analysis: DNA isolation and sequencing
The cecal contents of rats collected postmortem were stored at −80°C.
Metagenomic DNA was extracted from the cecal contents using a QIAamp-DNA stool
mini-kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions and
the adapted procedure described by Dewulf et al. [30]. High-throughput sequencing of
metagenomic samples was performed by DNAVision (Gosselies, Belgium). Brieﬂy, the
V1–V3 region of the bacterial 16S rRNA gene was ampliﬁed using barcoded primers 27f
(5′-CCTATCCCCTGTGTGCCTTGGCAGTCTCAG-3′) and 534r (5′-ATTACCGCGGCTGCTGG-
3′) [31], and puriﬁed ampliconswere analyzed on a Roche FLXGenome Sequencer using
titanium chemistry. The resulting Q25 reads were processed through the QIIME v1.7.0
pipeline [32]. Sequences were depleted of barcodes and primers, sequences b200 bp
or N1000 bp were removed, sequences with ambiguous base calls were removed, and
sequences with homopolymer runs exceeding 6 bpwere removed. The sequences were
then de-noised, and chimeraswere removed. Operational taxonomic units (OTUs)were
deﬁned by clustering at 3% divergence (97% similarity). The OTUs were then
taxonomically classiﬁed using BLASTn against a curated GreenGenes database.
2.8. Statistical analyses
Data are presented as the means±S.E. unless otherwise indicated. Differences
among groups were compared by analysis of variance followed by the Newman–Keuls
test to correct for multiple comparisons. Differences were considered statistically
signiﬁcant at Pb.05. Analyses were performed using GraphPad Prism (GraphPad
Software, San Diego, CA, USA).
Formicrobiota analyses, data are expressed as themeans±S.D. Differences between
groups were assessed using a two-tailed Student's t test. In the case of nondetectable
values for some samples, a nonparametric test was required, such as Fisher's Exact Test
to compare two groups at a time. Because most of the parameters had an abnormal
distribution (assessed using a Shapiro normality test), the correlations were analyzed
by Spearman's correlation. Data were analyzed using JMP 8.0.1 (SAS Institute, Inc., Cary,
NC, USA), R 3.0.2 (The R Foundation) and RStudio 0.97.310 with the package gplots for
the heatmap. The results were considered statistically signiﬁcant at Pb.05.
3. Results
3.1. Body composition and energy balance
Althoughdifferentmilk treatments provided similarmetabolizable
energy intake (Fig. 1D), we found that CM-treated animals exhibited
an increase in body weight gain (Fig. 1E) and body lipids percentage
(Fig. 1A) compared to control, whereas the sameparameters of DM- or
HM-treated animals were similar to control. A signiﬁcant increase in
body protein contentwas observed inHM-treated rats (Fig. 1B). In DM
and HM groups, we observed an increased energy expenditure
(Fig. 1F). Finally, the gross energy efﬁciency was signiﬁcantly
increased in CM-treated and signiﬁcantly decreased in DM-treated
animals compared to control animals. This parameterwas not affected
in HM-treated animals (Fig. 1G). The enhanced energy efﬁciency in
CM-treated animals was associated with higher lipid gain (Fig. 1H).In contrast, this parameter was markedly reduced in DM- and HM-
treated animals compared to controls. Protein gain (Fig. 1I) was
signiﬁcantly decreased in DM-treated animals and increased in the
other two groups, compared to control. In particular, HM-treated
animals showed a greater increase compared to the control.
3.2. Serum metabolites and inflammatory parameters
Serum glucose levels were signiﬁcantly lower in HM- and DM-fed
rats than in the other animals, HM-fed rats showed the lowest
insulin concentration among the groups. Consequently, a marked
reduction of homeostasis model assessment (HOMA) index was
observed in the DM and HM groups compared to controls, with HM
producing the lowest HOMA index (Table 1). Total cholesterol levels
were not affected by the different milks; however, triglycerides were
signiﬁcantly decreased in DM-fed animals and alanine aminotrans-
ferase (ALT) was signiﬁcantly decreased in HM-fed animals
(Table 1). Tumor necrosis factor α (TNF-α), interleukin (IL)-1 and
lipopolysaccharide (LPS) concentrations were signiﬁcantly de-
creased in HM- and DM-fed animals compared to control and CM-
fed rats, whereas monocyte chemoattractant protein-1 (MCP-1)
levels resulted unaffected by the different milks. IL-10 was increased
by two to three-fold in the treatment groups (HMNDMNCM) com-
pared to control (Table 2).
3.3. Mitochondrial efficiency and oxidative stress
Mitochondrial state 3 respiration using succinate or palmitoyl-
carnitine (fatty acid oxidation) as a substrate was increased in CM-
treated animals and further increased in DM- andHM-treated animals
compared to controls (Fig. 2A–C). State 3 respiration using glutamate
(Fig. 2B) as substrate and CPT activity (Fig. 2D) were increased in DM-
and HM-treated animals compared to control and CM-treated rats.
RCR valueswere indicative of high-qualitymitochondrial preparations
(data not shown).
After 4 weeks of treatment, the speciﬁc activity of citrate synthase
in isolated mitochondria was unchanged, whereas in liver homoge-
nates, the activity was higher in DM-treated animals and further
increased in HM-treated animals compared to control and CM-treated
rats (Fig. 2E). Therefore, a signiﬁcantly higher mitochondrial protein
contents (calculated as the ratio between citrate synthase activity in
the homogenate and isolated mitochondria) found in HM- and DM-
treated rats (HMNDM) indicate that the improved oxidative capacity
appears to be supported (at least in part) by an increased
mitochondrial mass (Fig. 2E). Mitochondrial basal and FFA-induced
proton leakage was increased in milk-treated animals (Fig. 2F–G)
compared to control. The effect on mitochondria basal leakage was
related to the type of milk used (HMNDMNCM) (Fig. 2F). In particular,
HM-treated animals exhibited the highest oxygen consumption
to maintain the same membrane potential among the groups. In
FFA-induced proton-leakage conditions, mitochondria from DM- and
CM-treated rats exhibited comparable kinetic curves (Fig. 2G). UCP2
signiﬁcantly increased after milk treatments, but this effect was more
pronounced in DM-treated animals (Fig. 2H).
Next, H2O2 yield and ROS-induced damage were measured in
mitochondria. H2O2 yield was signiﬁcantly increased in CM-treated
rats and was reduced in mitochondria from the HM and DM
groups (HMNDM) (Fig. 2I). Aconitase activity was signiﬁcantly
increased in DM and HM-treated rats compared to CM and control
rats (HMNDM) (Fig. 2L).
3.4. Antioxidant/detoxifying defences
Antioxidant state and cytoprotective enzyme activities are
improved by dietary supplementation with DM or HM. We
Fig. 3. Redox status and antioxidant/detoxifying defences. Total lipid (A), GSH (B) and GSSG content (C), GSH/GSSG ratio (D), GST (E) NQO1 activity (F), relative mRNA expression of
FGF21 (G), PGC1α (H), and PGC1β (I) were measured in the livers of differently treated rats. The results are expressed as the means±S.E. from n=7 animals/group. Different
superscripted letters indicate statistically signiﬁcant differences (Pb.05).
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increase in total GSH levels in the sera from HM-treated animals
(0.199±0.008 nmol/mg-protein/min) compared to controls (0.101
±0.003); to a lesser extent, we also found an increase of total GSH in
CM- and DM-supplemented rats (0.128±0.002 and 0.154±0.014 nmol/
mg-protein/min). At hepatic level, CM-treated rats exhibited a signiﬁ-
cantly higher percentage of lipids compared to other groups (Fig. 3A).
Reduced GSH levels were signiﬁcantly increased in animals supple-
mentedwith DMor HM compared to CM-treated or control rats (HM=
DMNCM=C) (Fig. 3B). Moreover, the beneﬁcial effects produced by the
HM and DM treatments on liver redox status were clearly indicated by
the marked decline in the GSSG content and the signiﬁcantly increased
GSH/GSSG ratios (Fig. 3C–D). In addition, the activity of NQO1 and GST
was signiﬁcantly higher in DM- or HM-treated rats compared to CM-
treated or control rats (Fig. 3E-F). In addition, because Nrf2 activation
was demonstrated to induce the expression of metabolic genes (PPARs,
FGF21) [5], we analyzed the expression of the PPARα, PPARγ, PGC1α,
PGC1β and FGF21 genes. No variation was observed in the expression
levels of PPARα, PPARγ (data not shown). The FGF21mRNA levels in DM
and HMwere signiﬁcantly decreased compared with CM rats (Fig. 3G).
The CM rats tended to increase the FGF21 mRNA levels in the liver,compared with control. However, this difference was not statistically
signiﬁcant (Fig. 3G). PGC1-α and PGC1-β mRNA levels signiﬁcantly
increased in CM compared to the other groups (Fig. 3H–I).
3.5. Gut microbiota composition
Gut microbiota composition was analyzed by pyrosequencing.
Bacteroidetes was increased in CM-fed rats (+22%) and Verrucomicro-
bia was decreased in DM-fed rats (−58%) compared to control. TM7
was increased(+575%) inDM-fed rats compared toCM-fed rats (Fig. 4).
Data on phylum differences are provided in Supplementary Table S4.
The abundances of 10 genera were signiﬁcantly affected by milk
treatments (Fig. 5). DM and HM similarly modiﬁed gut microbiota at
genera level (Supplementary Table S5).
The potential link between changes in gut microbiota composition
and host metabolic parameters following different milk treatments
was evaluated by a Spearman correlation coefﬁcient (Fig. 6). Strepto-
coccus and Lactococcus genera (increased in DM) and Coprobacillus
and Parabacteroides (increased in HM) were negatively correlated
with inﬂammatory markers (LPS and TNF-α) and fasting blood
glucose (Fig. 6). Moreover, these genera were positively correlated
Fig. 4. Milk treatments affect the proportions of different phyla. The composition of abundant bacterial phyla identiﬁed in gut microbiota of control and different milk-treated animals.
Undetected phyla are not represented on the pie chart. The signiﬁcant differences in speciﬁc phyla are shown in Supplementary Table 4.
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fatty acid oxidation rate (Fig. 6). In contrast, Akkermansia abundance was
positively correlated with fasting blood glucose, TNF-α and LPS levels.
Changes in Blautia and Syntrophococcus genera were both positively
correlated with antioxidant and anti-inﬂammatory markers (serum GSHFig. 5. Milk treatments affect the proportions of different genera. The composition of the bacte
control anddifferentmilk-treated animals. Each bar is set at 100% to illustrate the proportion of e
was not detected in this group of rats. Statistically signiﬁcant changes observed between diffeand IL-10). Blautia abundance (increased by all milks) was positively
correlated with fecal butyrate, mitochondrial respiratory capacity
and fatty acid oxidation rate. In addition, the signiﬁcant increase of
Syntrophococcus by HM (Supplementary Table S5) was positively
correlated with energy expenditure and body protein content (Fig. 6).rial genera signiﬁcantly affected by the treatments and identiﬁed in gut microbiota of
ach genera among the different groups; the absence of any color indicates that the genus
rent groups are shown in Supplementary Table 5.
Fig. 6. Spearman correlations heat map Heat map of the Spearman r correlations between the gut bacteria modiﬁed by the different milk supplements and biological parameters.
Correlations were performed on values for each rat in every group.
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An increase in fecal butyrate and propionate levelswas observed in
animals treated with DM or HM, but not CM, compared with control
rats. The effect was two-fold greater in DM-treated compared with
HM-treated animals (Fig. 7).
4. Discussion
In this study, we compared the nutritional, immunomodulatory
and antioxidant effects of iso-energetic supplementation with milk
from three distinct animals: two that are monogastric (HM and DM)
and one that is polygastric (CM). We recently showed the efﬁcacy of
DM in decreasing the accumulation of body lipids and its ability to
improve the use of fat as metabolic fuel for hepatic mitochondria [33].
Here, we demonstrate that these biological effects are comparable
with those elicited by HM. Although these different milks resulted inFig. 7. SCFAs concentrations fecal butyrate (A) and propionate (B) levels were reported. The res
letters indicate statistically signiﬁcant differences (Pb.05).similar increases inmetabolizable energy, DMandHMhadnoeffect on
body weight gain but were able to increase energy expenditure
compared with CM. The enhanced energy efﬁciency found in CM-fed
animals was associatedwith higher total body and liver lipid levels; in
contrast, these values were markedly reduced in DM-and HM-fed
animals. In HM-fed rats, it is likely that the decrease in adiposity can be
explained by increased fatty acid oxidation; however, we cannot
exclude that this effect may also be due to lower plasma insulin levels.
The roles that essential fatty acids, enzymes, hormones, growth factors
and other biologically active compounds play in the effects of HM and
DM on lipid metabolism merit further consideration. The observed
differences in body protein content suggest some interesting
perspectives. The quality of proteins, with respect to their essential
amino acid content, may be responsible for the difference observed.
However, we cannot rule out that this effect on protein gain may also
be due to the high concentration of growth factors in HM that are
essential for the proliferation and differentiation of body tissues [34].ults are expressed as the means±S.E. from n=7 animals/group. Different superscripted
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homeostasis by inducing a dampened glycemic response compared to
CM and the lowest insulin levels and HOMA index compared to other
milks. These results are consistent with Gunnerud et al. [35]. Other
data show that the insulin response to milk is not only due to the
lactose component but is also related to the whey fraction [36] and to
bioactive peptides in the milk or secreted in the gastrointestinal tract
[37]. Moreover, glucose-regulating hormones, such as leptin, adipo-
nectin, resistin and ghrelin, detected in HM [38], may be involved in
the regulation of growth in infancy and might inﬂuence the
programming of energy balance with long-term consequences on
health [13]. Other studies highlight the correlation between low blood
glucose and insulin in infancy and low insulin levels in adulthood,
suggesting a protective role of breastfeeding against type 2 diabetes
and obesity in later life [39]. It is noteworthy that in the rat model, DM
affects glucose metabolism in a manner more similar to HM than CM,
suggesting that in addition to providing a hypoallergenic milk
substitute for children affected by CM protein allergies, DM might
have beneﬁcial effects by changing energy homeostasis in favor of
fatty acid oxidation, thereby reducing fat storage. However, this
speculation warrants further investigation in humans. Moreover, the
metabolic beneﬁts on bodyweight and glucose control induced byHM
and DM may be related to the modulation of the gut microbiota. We
and others have previously shown that the gut microbiota plays a
major role in energy storage and glucose homeostasis [40,41]. Among
the metabolites produced by the gut microbiota, SCFAs have been
shown to play a major role [42,43]. We can speculate that the marked
increase in SCFAs in both DM- andHM-treated rats can be responsible,
at least in part, to beneﬁcial effects found in these animals. Finally, the
effects of SCFAs have been described in several studies and have been
shown to reduce diet-induced obesity and to increase energy
expenditure [42–44].
The effect of different milks on nutritional status is controlled by
multiple mechanisms. Considering the central role of the liver in
energy expenditure and lipid and glucose metabolism, we evaluated
hepatic mitochondrial function and efﬁciency.
We observed similar biological responses in rats fed with DM or
HM; in particular, the beneﬁcial effects of DM administration are
further enhanced in rats treated with HM. HM-fed rats exhibited
increased respiratory capacity andmitochondrial mass and decreased
oxidative stress in their liver mitochondria even when the ability to
utilize fat as a metabolic fuel was increased. The increased mitochon-
drial fatty acid oxidation observed in the liver is likely related to an
enhancement of CPT activity, which would further increase the entry
of long-chain FFAs into the mitochondria. The consequent increase in
lipid oxidation is apparently sufﬁcient to handle the decreased load of
hepatic FFAs and body adiposity.
A concomitant decline in mitochondrial energy efﬁciency (ther-
mogenic effect), as evidenced by the increased proton-leakage and
increased UCP2 protein content in HM-fed rats, may also contribute to
burning the fat in these animals. Indeed, in addition to stimulating
fatty acid oxidation in the liver, HM induced a less efﬁcient utilization
of lipid substrates through the stimulation of a thermogenic
mechanism, such as proton leakage. We speculate that HM-fed
animals (similarly to DM-treated rats) might be protected from the
development of obesity through this mechanism; however, this
hypothesis requires further investigation. In addition, the reduction
of mitochondrial oxidative stress parameters (H2O2 production and
aconitase activity) can result from the concomitant increase in proton
leakage, which was reported as a major mechanism involved in the
modulation of membrane potential to control mitochondrial ROS
emission [3]. The observed beneﬁcial effects elicited by DM intake on
the antioxidant status (GSH/GSSG ratio) and on detoxifying enzyme
activities (GST-NQO1) conﬁrm previous ﬁndings [33]. Notably, the
comparable enhancement of antioxidant/detoxifying defences by DMand HM intake is attributable, at least in part, to the activation of the
Nrf2–ARE pathway and further supports the feasibility of DM as an
ideal HM substitute. Moreover, Nrf2 may exert a control on the stress
hormones FGF21 [45], an important factor in the homeostatic
mechanisms regulating glucose and lipid metabolism [46]. Impor-
tantly, the activation of Nrf2 in DM and HM rats is signiﬁcantly
associated with lower mRNA expression levels of FGF21, whereas the
increased FGF21 expression in CM group if compared to DM or HM
rats, together with high hepatic lipid content and H2O2 yield, is in line
with the expression of PGC1 that in previous studies was showed
necessary for the FGF21 protective effects in liver damage conditions,
regulates ROS homeostasis and mitochondrial biogenesis [47].
Moreover, due to the recognition of the gut–liver axis and on the
basis of the recent studies reporting the in vivo and in vitro ability of
butyrate to modulate the Nrf2–ARE pathway [48,49], our data
showing increased concentrations of fecal butyrate in HM- and DM-
treated rats led us to hypothesize that an improved Nrf2 defence may
result from the increased levels of butyrate-producing microbiota in
these animals. Finally, the reported association of enhanced anti-
inﬂammatory defences with Nrf2 signaling [50] prompted us to
evaluate the consequences of DM and HM intake on the levels of
several proinﬂammatory indicators. The beneﬁcial effects producedby
HM and DM intake were indicated by lower TNF-α and IL-1
concentrations, decreased LPS levels (marker of metabolic and
inﬂammatory diseases) [44] and increased IL-10.
Here, we investigated the impact of CM, DM and HM dietary
supplementation on the gut microbiota composition. We found that
DM and HM affected the gut microbiota in favor of two genera that
have been linked with anti-inﬂammatory properties: Bacteroides and
Parabacteroides. Importantly, these bacterial species are known to
produce SCFAs [51]. It isworth noting thatwe found an increased level
of fecal SCFAs in animals fed with DM and HM. Recent evidence
suggests that the genus Parabacteroides may be associated with an
improved intestinal integrity and a lower inﬂammatory tone [52].
In agreement, we also found (by Spearman correlation) that
Parabacteroides abundance was negatively associated with several
inﬂammatory markers. Moreover, an increase of Syntrophococcus and
Blautia genera in milk-treated rats was observed. Interestingly, these
two genera were correlated with different biological parameters. For
instance, Syntrophococcus, which was increased in the HM-treated
group, is positively related to body protein content and gain, whereas
Blautia, which was signiﬁcantly increased in the DM-treated group, is
positively associated with mitochondrial respiratory capacity. It is
worth noting that in patients affected by hepatic encephalopathy, the
presence of Blautiawas associatedwith good cognition, lower severity
of liver disease and decreased inﬂammation [53]. We did not ﬁnd any
differences among the groups in Lactobacillus genera; however, we
observed a signiﬁcantly higher rate of Streptococcus and Lactococcus in
DM-treated rats than in other groups. It was previously shown that a
probiotic combination containing Streptococcus thermophilus protects
the bowel and improves colonic inﬂammation in experimentally
induced inﬂammatory bowel disease in rats [54]. Our ﬁndings support
this hypothesis because Streptococcus and Lactococcuswere negatively
correlated with inﬂammatory parameters (TNF-α, LPS and H2O2
yield). We also analyzed Akkermansia rate. This species was isolated
from the human intestinal tract due to its efﬁcient use of mucus as a
carbon and nitrogen source, and it is associated with the protective
mucosal lining of the intestine. We and others have previously shown
that Akkermansia muciniphila abundance is correlated with an
improved metabolic proﬁle [55,56]. In addition, it was demonstrated
that A.muciniphila treatment reversed high fat diet-inducedmetabolic
disorders by restoring the gut mucus layer that is disrupted with
obesity and type 2 diabetes [55]. It is likely that A. muciniphila
regulates gut barrier function at different levels. Excessive mucin
degradation by intestinal bacteria may contribute to inﬂammatory
Fig. 8. Model depicting the effects of distinct milks supplementation on, lipid and glucosemetabolism, inﬂammatory and oxidative stress bymodulatingmitochondrial function and gut
microbiota. To assess the effects of distinct milks supplementation on energy balance and redox state, it is crucial to understand how mitochondrial function and gut microbiota
composition interactwith host and participate in themetabolic response to diet. Themodulation of Nrf2 pathway and the bacterialmetabolism of nutrients in the gut,with the release of
bioactive compounds (SCFAs), promote competitive interactions with host cellular targets to control energy metabolism and inﬂammatory state. Nrf2 pathway is induced by DM and
HM and leads to a decrease in FGF21 expression. In contrast, in CM rats, the lacking activation of Nrf2 abolishes its inhibitory effect on FGF21 modulating mitochondrial biogenesis by
PGC1. DM and HM affect gut microbiota composition with an increase in SCFAs which in turn modulate Nrf2. The correlation between gut microbiota and inﬂammatory parameters is
conﬁrmed by Spearman analyses.
1145G. Trinchese et al. / Journal of Nutritional Biochemistry 26 (2015) 1136–1146bowel diseases because the access of luminal antigens to the intestinal
immune system is facilitated, whereas in pathological conditions, A.
muciniphila seems to improve intestinal response by increasingmucus
production and the number of goblet cells [55]. In this study, no
increase of Akkermansia was found in the treated groups; instead a
signiﬁcant reduction of its presence was observed in DM-treated rats
and was positively correlated with fasting glucose, TNF-α and
LPS levels. Whether the beneﬁcial effects of the different milks
observed in our study are mediated through this genus warrants
further investigation.
The present study highlights that dietary supplementation with
HM or DM is associated with a decrease of inﬂammatory status. This
decrease is associated with the improvement of lipid and glucose
metabolism. In addition, our observations indicate that the beneﬁcial
effects elicited by HM and DM are, at least in part, mediated by their
ability to modulate mitochondrial function and efﬁciency, ROS
homeostasis and Nrf2–FGF21 pathways. Moreover, we found that
speciﬁc gut microbes and metabolites (SCFAs) were increased upon
HM and DM feeding, thereby linking gut microbiota with host
metabolism (Fig. 8).
Altogether, our study adds further support to the exceptional
qualities of HMandDMcompared to CM. Thus, the impact ofmilk from
ruminants differs from that of monogastric species on gut microbes
and host metabolism at different levels (energy storage, energy
expenditure, mitochondrial function, metabolism and inﬂammation).
Whether the physicochemical and nutritional properties can explain
the distinctive nutritional, sensory and metabolic characteristics
among the different milks requires further studies. Finally, nature
provided humans, just as all mammalian species, with a milk
especially suited not only to the nutritional needs of the respective
infants but also to the promotion of future health and development.
Nevertheless, by displaying novel mechanisms linking gut microbesandmitochondrial function with cellular metabolic responses accord-
ing to themilk used, this study adds novel signiﬁcant perspectives and
suggests that selected milks may provide protection against speciﬁc
metabolic disorders.
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